As of 2025-03-17, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (8.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -221.9%.
The range of the Relative Valuation is (3.90) - (13.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 16.5x | 10.6x |
| Forward P/E multiples | 4.6x - 15.4x | 10.0x |
| Fair Price | (3.90) - (13.07) | (8.72) |
| Upside | -154.6% - -282.8% | -221.9% |
| Date | P/E |